Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Giunta

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Cellular and Molecular Life Sciences : CMLS|August 20, 2014
The impact of HIV-1 on neurogenesis: implications for HANDDarren Ferrell, Brian Giunta
CNS & Neurological Disorders Drug Targets|March 9, 2010
Impact of the CD40-CD40L dyad in Alzheimer's diseaseBrian Giunta, Kavon Rezai-Zadeh, Jun Tan
International Journal of Physiology, Pathophysiology and Pharmacology|October 17, 2012
The role of glycogen synthase kinase-3 signaling in neurodevelopment and fragile X syndromeSamantha Portis, Brian Giunta, Demian Obregon, et al.
Rejuvenation Research|September 16, 2008
Blueberry opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activation protein kinaseYuyan Zhu, Paula C Bickford, Paul Sanberg, et al.
American Journal of Translational Research|March 19, 2011
Evaluation of a novel supplement to reduce blood glucose through the use of a modified oral glucose tolerance testAdam J Smith, Brian Giunta, R Douglas Shytle, et al.
International Journal of Clinical and Experimental Pathology|September 12, 2008
HIV-1 TAT inhibits microglial phagocytosis of Abeta peptideBrian Giunta, Yuyan Zhou, Huayan Hou, et al.
American Journal of Translational Research|September 1, 2012
HIV-1 Tat-induced microglial activation and neuronal damage is inhibited via CD45 modulation: A potential new treatment target for HANDJingji Jin, Lucy Lam, Edin Sadic, et al.
Nature Reviews. Neurology|July 4, 2012
Immunotherapy for Alzheimer disease: the challenge of adverse effectsYu-Hui Liu, Brian Giunta, Hua-Dong Zhou, et al.
American Journal of Translational Research|April 21, 2015
MSM ameliorates HIV-1 Tat induced neuronal oxidative stress via rebalance of the glutathione cycleSeol-Hee Kim, Adam J Smith, Jun Tan, et al.
International Review of Neurobiology|June 9, 2009
Normal brain aging clinical, immunological, neuropsychological, and neuroimaging featuresMaria T Caserta, Yvonne Bannon, Francisco Fernandez, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Cellular and Molecular Life Sciences : CMLS|August 20, 2014
The impact of HIV-1 on neurogenesis: implications for HANDDarren Ferrell, Brian Giunta
CNS & Neurological Disorders Drug Targets|March 9, 2010
Impact of the CD40-CD40L dyad in Alzheimer's diseaseBrian Giunta, Kavon Rezai-Zadeh, Jun Tan
International Journal of Physiology, Pathophysiology and Pharmacology|October 17, 2012
The role of glycogen synthase kinase-3 signaling in neurodevelopment and fragile X syndromeSamantha Portis, Brian Giunta, Demian Obregon, et al.
Rejuvenation Research|September 16, 2008
Blueberry opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activation protein kinaseYuyan Zhu, Paula C Bickford, Paul Sanberg, et al.
American Journal of Translational Research|March 19, 2011
Evaluation of a novel supplement to reduce blood glucose through the use of a modified oral glucose tolerance testAdam J Smith, Brian Giunta, R Douglas Shytle, et al.
International Journal of Clinical and Experimental Pathology|September 12, 2008
HIV-1 TAT inhibits microglial phagocytosis of Abeta peptideBrian Giunta, Yuyan Zhou, Huayan Hou, et al.
American Journal of Translational Research|September 1, 2012
HIV-1 Tat-induced microglial activation and neuronal damage is inhibited via CD45 modulation: A potential new treatment target for HANDJingji Jin, Lucy Lam, Edin Sadic, et al.
Nature Reviews. Neurology|July 4, 2012
Immunotherapy for Alzheimer disease: the challenge of adverse effectsYu-Hui Liu, Brian Giunta, Hua-Dong Zhou, et al.
American Journal of Translational Research|April 21, 2015
MSM ameliorates HIV-1 Tat induced neuronal oxidative stress via rebalance of the glutathione cycleSeol-Hee Kim, Adam J Smith, Jun Tan, et al.
International Review of Neurobiology|June 9, 2009
Normal brain aging clinical, immunological, neuropsychological, and neuroimaging featuresMaria T Caserta, Yvonne Bannon, Francisco Fernandez, et al.
Pageof 6